Review



dll1 fc  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems dll1 fc
    Dll1 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+dll1/pmc12643260-429-4-5?v=R%26D+Systems
    Average 93 stars, based on 4 article reviews
    dll1 fc - by Bioz Stars, 2026-08
    93/100 stars

    Images



    Similar Products

    92
    Sino Biological lgmn human recombinant protein
    a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg <t>of</t> <t>DLL1</t> ( l , m ) or <t>LGMN</t> ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.
    Lgmn Human Recombinant Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+dll1/pmc10853283-256-2-9?v=Sino+Biological
    Average 92 stars, based on 1 article reviews
    lgmn human recombinant protein - by Bioz Stars, 2026-08
    92/100 stars
      Buy from Supplier

    93
    Bio-Techne corporation 10184 dl 050 biotechne
    a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg <t>of</t> <t>DLL1</t> ( l , m ) or <t>LGMN</t> ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.
    10184 Dl 050 Biotechne, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+dll1/pm37971882-249-36-37?v=Bio-Techne+corporation
    Average 93 stars, based on 1 article reviews
    10184 dl 050 biotechne - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    R&D Systems dll1 fc
    a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg <t>of</t> <t>DLL1</t> ( l , m ) or <t>LGMN</t> ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.
    Dll1 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+dll1/pmc12643260-429-4-5?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    dll1 fc - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    94
    R&D Systems jg 050 dll1 fc r d systems
    a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg <t>of</t> <t>DLL1</t> ( l , m ) or <t>LGMN</t> ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.
    Jg 050 Dll1 Fc R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+dll1/pm39383865-270-42-44?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    jg 050 dll1 fc r d systems - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    93
    R&D Systems soluble notch ligands dll1 fc
    a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg <t>of</t> <t>DLL1</t> ( l , m ) or <t>LGMN</t> ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.
    Soluble Notch Ligands Dll1 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+dll1/pmc10546201-90-0-13?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    soluble notch ligands dll1 fc - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    R&D Systems dll 1
    a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg <t>of</t> <t>DLL1</t> ( l , m ) or <t>LGMN</t> ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.
    Dll 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+dll1/pm37451260-294-45-46?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    dll 1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    Image Search Results


    a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg of DLL1 ( l , m ) or LGMN ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R

    doi: 10.1038/s41467-024-45223-0

    Figure Lengend Snippet: a – d Blood glucose ( a , n = 5 per group), plasma insulin ( b , n = 5 per group), plasma leptin ( c , n = 5 per group), and plasma ghrelin ( d , n = 4 Control d14, n = 6 Control d14 + 3, n = 2 ExpOF d14, n = 3 ExpOF d14 + 3) levels at different time points during the overfeeding intervention. e Fgf21 expression in eWAT, iWAT, iBAT, and liver ( n = 6). f Plasma FGF21 levels ( n = 6). g Schematic overview of the ExpOF setup in chow-fed FGF21 KO mice. Created with BioRender.com. h Body weight changes (percentage over baseline) in control ( n = 4) and ExpOF ( n = 5) FGF21 KO mice. Body weight is set at 100% at d0 (start of ExpOF). i Absolute body weight of same mice shown in h on day 0, 14, and 21. j Daily total (light pink for control mice, dark pink for ExpOF mice) and voluntary (purple for ExpOF mice) energy intake of same mice shown in h . k Heatmap showing average changes of top 20 regulated proteins (sorted by adjusted p value) between control and ExpOF mice at d14 and d14 + 3 ( n = 6). Heatmap shows fold-changes in normalized protein expression relative to control d14 mice. Red indicates high relative protein abundance and blue indicates low relative protein abundance. Regulated proteins (FDR < 0.1) are highlighted in bold. l – o Effects on food intake ( l , n ), and body weight ( m , o ) in C57BL/6 J DIO male mice injected once with 1 mg/kg of DLL1 ( l , m ) or LGMN ( n , o ) human recombinant proteins or vehicle ( n = 8 per group). p , q Open field test running traces ( p ) and total distance ( q ) of chow-fed lean C57BL6/J mice injected with LGMN (1 mg/kg) or vehicle ( n = 10 per group). Data shown as mean ± SEM with individual values plotted ( d – f , I , m , o , q ). P values were calculated using 2-way ANOVA using overfeeding and time as factors ( a – f , h – j , l , n ), or unpaired two-tailed Welch’s t test ( m , o , q ). */**/*** was used when p < 0.05, p < 0.01, p < 0.001, respectively, in Welch’s t test or post hoc comparison after ANOVA ( a – c , i , l – o ). */#/$; **/##/$$; ***/###/$$$ were used when p < 0.05; p < 0.01; p < 0.001, for overfeeding/time/interaction effects, respectively ( d – f ). ns: non-significant. n : number of mice (biological replicates). Source data are provided as a Source Data file.

    Article Snippet: DLL1 and LGMN human recombinant protein were obtained from Sino Biological (#11635-H08H) and Cusabio (#EP012903HU), respectively.

    Techniques: Expressing, Injection, Recombinant, Two Tailed Test, Comparison